Highbridge Capital Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History
Bought
Maintained
Sold
Other funds holding RVPH
Highbridge Capital Management's RVPH Position: Q2 2026 in Review
Highbridge Capital Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 762,236 shares — an estimated $556K sold.
Highbridge Capital Management first reported a position in RVPH in Q1 2026 and held it in 1 quarter. The position peaked at $556K in Q1 2026. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.
- Highbridge Capital Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
- Highbridge Capital Management sold 762,236 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $556K.
- Highbridge Capital Management first reported a position in REVIVA PHARMA HLDGS INC in Q1 2026 and held it in 1 quarter.
- Highbridge Capital Management's REVIVA PHARMA HLDGS INC position peaked at $556K in Q1 2026.
- 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.
Based on Highbridge Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.